The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Nasal Vaccines Market Research Report 2024

Global Nasal Vaccines Market Research Report 2024

Publishing Date : Jun, 2023

License Type :
 

Report Code : 1615362

No of Pages : 96

Ask Your Query

Global Nasal Vaccines market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Nasal Vaccines market research.

Key manufacturers engaged in the Nasal Vaccines industry include Sanofi, AstraZeneca, Abbott, GlaxoSmithKline, Serum Institute of India, Bharat Biotech, Antares Pharma, INJEX Pharma GmbH and BioDiem, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.

When refers to consumption region, % volume of Nasal Vaccines were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Nasal Vaccines market and estimated to attract more attentions from industry insiders and investors.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Nasal Vaccines market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company(Partial List)

  •     Sanofi
  •     AstraZeneca
  •     Abbott
  •     GlaxoSmithKline
  •     Serum Institute of India
  •     Bharat Biotech
  •     Antares Pharma
  •     INJEX Pharma GmbH
  •     BioDiem
  •     PharmaJet and Crossject

Segment by Type

  •     Flu Vaccines
  •     COVID-19 Vaccines
  •     Other Vaccines

Segment by Application

  •     Adult
  •     Children

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina, Colombia)

The Nasal Vaccines report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source

1 Nasal Vaccines Market Overview
    1.1 Product Overview and Scope of Nasal Vaccines
    1.2 Nasal Vaccines Segment by Type
        1.2.1 Global Nasal Vaccines Market Value Comparison by Type (2023-2029)
        1.2.2 Flu Vaccines
        1.2.3 COVID-19 Vaccines
        1.2.4 Other Vaccines
    1.3 Nasal Vaccines Segment by Application
        1.3.1 Global Nasal Vaccines Market Value by Application: (2023-2029)
        1.3.2 Adult
        1.3.3 Children
    1.4 Global Nasal Vaccines Market Size Estimates and Forecasts
        1.4.1 Global Nasal Vaccines Revenue 2018-2029
        1.4.2 Global Nasal Vaccines Sales 2018-2029
        1.4.3 Global Nasal Vaccines Market Average Price (2018-2029)
    1.5 Assumptions and Limitations

 2 Nasal Vaccines Market Competition by Manufacturers
    2.1 Global Nasal Vaccines Sales Market Share by Manufacturers (2018-2023)
    2.2 Global Nasal Vaccines Revenue Market Share by Manufacturers (2018-2023)
    2.3 Global Nasal Vaccines Average Price by Manufacturers (2018-2023)
    2.4 Global Nasal Vaccines Industry Ranking 2021 VS 2022 VS 2023
    2.5 Global Key Manufacturers of Nasal Vaccines, Manufacturing Sites & Headquarters
    2.6 Global Key Manufacturers of Nasal Vaccines, Product Type & Application
    2.7 Nasal Vaccines Market Competitive Situation and Trends
        2.7.1 Nasal Vaccines Market Concentration Rate
        2.7.2 The Global Top 5 and Top 10 Largest Nasal Vaccines Players Market Share by Revenue
        2.7.3 Global Nasal Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

 3 Nasal Vaccines Retrospective Market Scenario by Region
    3.1 Global Nasal Vaccines Market Size by Region: 2018 Versus 2022 Versus 2029
    3.2 Global Nasal Vaccines Global Nasal Vaccines Sales by Region: 2018-2029
        3.2.1 Global Nasal Vaccines Sales by Region: 2018-2023
        3.2.2 Global Nasal Vaccines Sales by Region: 2024-2029
    3.3 Global Nasal Vaccines Global Nasal Vaccines Revenue by Region: 2018-2029
        3.3.1 Global Nasal Vaccines Revenue by Region: 2018-2023
        3.3.2 Global Nasal Vaccines Revenue by Region: 2024-2029
    3.4 North America Nasal Vaccines Market Facts & Figures by Country
        3.4.1 North America Nasal Vaccines Market Size by Country: 2018 VS 2022 VS 2029
        3.4.2 North America Nasal Vaccines Sales by Country (2018-2029)
        3.4.3 North America Nasal Vaccines Revenue by Country (2018-2029)
        3.4.4 United States
        3.4.5 Canada
    3.5 Europe Nasal Vaccines Market Facts & Figures by Country
        3.5.1 Europe Nasal Vaccines Market Size by Country: 2018 VS 2022 VS 2029
        3.5.2 Europe Nasal Vaccines Sales by Country (2018-2029)
        3.5.3 Europe Nasal Vaccines Revenue by Country (2018-2029)
        3.5.4 Germany
        3.5.5 France
        3.5.6 U.K.
        3.5.7 Italy
        3.5.8 Russia
    3.6 Asia Pacific Nasal Vaccines Market Facts & Figures by Country
        3.6.1 Asia Pacific Nasal Vaccines Market Size by Country: 2018 VS 2022 VS 2029
        3.6.2 Asia Pacific Nasal Vaccines Sales by Country (2018-2029)
        3.6.3 Asia Pacific Nasal Vaccines Revenue by Country (2018-2029)
        3.6.4 China
        3.6.5 Japan
        3.6.6 South Korea
        3.6.7 India
        3.6.8 Australia
        3.6.9 China Taiwan
        3.6.10 Indonesia
        3.6.11 Thailand
        3.6.12 Malaysia
    3.7 Latin America Nasal Vaccines Market Facts & Figures by Country
        3.7.1 Latin America Nasal Vaccines Market Size by Country: 2018 VS 2022 VS 2029
        3.7.2 Latin America Nasal Vaccines Sales by Country (2018-2029)
        3.7.3 Latin America Nasal Vaccines Revenue by Country (2018-2029)
        3.7.4 Mexico
        3.7.5 Brazil
        3.7.6 Argentina
        3.7.7 Colombia
    3.8 Middle East and Africa Nasal Vaccines Market Facts & Figures by Country
        3.8.1 Middle East and Africa Nasal Vaccines Market Size by Country: 2018 VS 2022 VS 2029
        3.8.2 Middle East and Africa Nasal Vaccines Sales by Country (2018-2029)
        3.8.3 Middle East and Africa Nasal Vaccines Revenue by Country (2018-2029)
        3.8.4 Turkey
        3.8.5 Saudi Arabia
        3.8.6 UAE

 4 Segment by Type
    4.1 Global Nasal Vaccines Sales by Type (2018-2029)
        4.1.1 Global Nasal Vaccines Sales by Type (2018-2023)
        4.1.2 Global Nasal Vaccines Sales by Type (2024-2029)
        4.1.3 Global Nasal Vaccines Sales Market Share by Type (2018-2029)
    4.2 Global Nasal Vaccines Revenue by Type (2018-2029)
        4.2.1 Global Nasal Vaccines Revenue by Type (2018-2023)
        4.2.2 Global Nasal Vaccines Revenue by Type (2024-2029)
        4.2.3 Global Nasal Vaccines Revenue Market Share by Type (2018-2029)
    4.3 Global Nasal Vaccines Price by Type (2018-2029)

 5 Segment by Application
    5.1 Global Nasal Vaccines Sales by Application (2018-2029)
        5.1.1 Global Nasal Vaccines Sales by Application (2018-2023)
        5.1.2 Global Nasal Vaccines Sales by Application (2024-2029)
        5.1.3 Global Nasal Vaccines Sales Market Share by Application (2018-2029)
    5.2 Global Nasal Vaccines Revenue by Application (2018-2029)
        5.2.1 Global Nasal Vaccines Revenue by Application (2018-2023)
        5.2.2 Global Nasal Vaccines Revenue by Application (2024-2029)
        5.2.3 Global Nasal Vaccines Revenue Market Share by Application (2018-2029)
    5.3 Global Nasal Vaccines Price by Application (2018-2029)

 6 Key Companies Profiled
    6.1 Sanofi
        6.1.1 Sanofi Corporation Information
        6.1.2 Sanofi Description and Business Overview
        6.1.3 Sanofi Nasal Vaccines Sales, Revenue and Gross Margin (2018-2023)
        6.1.4 Sanofi Nasal Vaccines Product Portfolio
        6.1.5 Sanofi Recent Developments/Updates
    6.2 AstraZeneca
        6.2.1 AstraZeneca Corporation Information
        6.2.2 AstraZeneca Description and Business Overview
        6.2.3 AstraZeneca Nasal Vaccines Sales, Revenue and Gross Margin (2018-2023)
        6.2.4 AstraZeneca Nasal Vaccines Product Portfolio
        6.2.5 AstraZeneca Recent Developments/Updates
    6.3 Abbott
        6.3.1 Abbott Corporation Information
        6.3.2 Abbott Description and Business Overview
        6.3.3 Abbott Nasal Vaccines Sales, Revenue and Gross Margin (2018-2023)
        6.3.4 Abbott Nasal Vaccines Product Portfolio
        6.3.5 Abbott Recent Developments/Updates
    6.4 GlaxoSmithKline
        6.4.1 GlaxoSmithKline Corporation Information
        6.4.2 GlaxoSmithKline Description and Business Overview
        6.4.3 GlaxoSmithKline Nasal Vaccines Sales, Revenue and Gross Margin (2018-2023)
        6.4.4 GlaxoSmithKline Nasal Vaccines Product Portfolio
        6.4.5 GlaxoSmithKline Recent Developments/Updates
    6.5 Serum Institute of India
        6.5.1 Serum Institute of India Corporation Information
        6.5.2 Serum Institute of India Description and Business Overview
        6.5.3 Serum Institute of India Nasal Vaccines Sales, Revenue and Gross Margin (2018-2023)
        6.5.4 Serum Institute of India Nasal Vaccines Product Portfolio
        6.5.5 Serum Institute of India Recent Developments/Updates
    6.6 Bharat Biotech
        6.6.1 Bharat Biotech Corporation Information
        6.6.2 Bharat Biotech Description and Business Overview
        6.6.3 Bharat Biotech Nasal Vaccines Sales, Revenue and Gross Margin (2018-2023)
        6.6.4 Bharat Biotech Nasal Vaccines Product Portfolio
        6.6.5 Bharat Biotech Recent Developments/Updates
    6.7 Antares Pharma
        6.6.1 Antares Pharma Corporation Information
        6.6.2 Antares Pharma Description and Business Overview
        6.6.3 Antares Pharma Nasal Vaccines Sales, Revenue and Gross Margin (2018-2023)
        6.4.4 Antares Pharma Nasal Vaccines Product Portfolio
        6.7.5 Antares Pharma Recent Developments/Updates
    6.8 INJEX Pharma GmbH
        6.8.1 INJEX Pharma GmbH Corporation Information
        6.8.2 INJEX Pharma GmbH Description and Business Overview
        6.8.3 INJEX Pharma GmbH Nasal Vaccines Sales, Revenue and Gross Margin (2018-2023)
        6.8.4 INJEX Pharma GmbH Nasal Vaccines Product Portfolio
        6.8.5 INJEX Pharma GmbH Recent Developments/Updates
    6.9 BioDiem
        6.9.1 BioDiem Corporation Information
        6.9.2 BioDiem Description and Business Overview
        6.9.3 BioDiem Nasal Vaccines Sales, Revenue and Gross Margin (2018-2023)
        6.9.4 BioDiem Nasal Vaccines Product Portfolio
        6.9.5 BioDiem Recent Developments/Updates
    6.10 PharmaJet and Crossject
        6.10.1 PharmaJet and Crossject Corporation Information
        6.10.2 PharmaJet and Crossject Description and Business Overview
        6.10.3 PharmaJet and Crossject Nasal Vaccines Sales, Revenue and Gross Margin (2018-2023)
        6.10.4 PharmaJet and Crossject Nasal Vaccines Product Portfolio
        6.10.5 PharmaJet and Crossject Recent Developments/Updates

 7 Industry Chain and Sales Channels Analysis
    7.1 Nasal Vaccines Industry Chain Analysis
    7.2 Nasal Vaccines Key Raw Materials
        7.2.1 Key Raw Materials
        7.2.2 Raw Materials Key Suppliers
    7.3 Nasal Vaccines Production Mode & Process
    7.4 Nasal Vaccines Sales and Marketing
        7.4.1 Nasal Vaccines Sales Channels
        7.4.2 Nasal Vaccines Distributors
    7.5 Nasal Vaccines Customers

 8 Nasal Vaccines Market Dynamics
    8.1 Nasal Vaccines Industry Trends
    8.2 Nasal Vaccines Market Drivers
    8.3 Nasal Vaccines Market Challenges
    8.4 Nasal Vaccines Market Restraints

 9 Research Finding and Conclusion

 10 Methodology and Data Source
    10.1 Methodology/Research Approach
        10.1.1 Research Programs/Design
        10.1.2 Market Size Estimation
        10.1.3 Market Breakdown and Data Triangulation
    10.2 Data Source
        10.2.1 Secondary Sources
        10.2.2 Primary Sources
    10.3 Author List
    10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock